Mechanism-oriented interventions show promising results for taxane-induced neuropathic pain in breast cancer survivors.

A systematic review and critical assessment examined the efficacy of mechanism-oriented interventions for managing taxane-induced neuropathic pain (TINP) in breast cancer survivors. The scope included pharmacological treatments, invasive and non-invasive neuromodulation techniques, physical activity, manual therapies such as acupuncture and massage, and cryotherapy. The review synthesized evidence from studies with small sample sizes and frequent heterogeneity in study designs. Many included studies classified TINP as a secondary outcome rather than a primary focus, which may limit the depth of the available data.

The main results indicated promising results for clinical and experimental interventions targeting both peripheral and central pathways. However, specific effect sizes, absolute numbers, and statistical measures such as p-values or confidence intervals were not reported in the available data. Secondary outcomes related to mitochondrial dysfunction, oxidative stress, axonal degeneration, maladaptive neuroplasticity, and neuroimmune activation were also assessed but lacked quantitative detail in this summary.

Safety and tolerability data were not reported for the interventions reviewed. Adverse events, serious adverse events, discontinuations, and overall tolerability profiles remained uncharacterized in the source material. Key limitations included the small sample sizes across studies, the heterogeneity in study designs, and the frequent classification of TINP as a secondary outcome. These factors contribute to uncertainty regarding the generalizability of the findings.

The practice relevance highlights a clear need for more methodologically rigorous studies, particularly those involving mechanism-oriented interventions, in the context of TINP rehabilitation for breast cancer patients. Until higher-quality evidence emerges, clinicians should consider these interventions as potentially promising but unproven options that require careful patient selection and monitoring.